Eduardo Locatelli MD MPH
NSU Neuroscience Institute
Physician Executive Director
Eduardo Locatelli, M.D., M.P.H.
Dr. Locatelli is the David and Cathy Husman Endowed Chair of the Neuroscience Institute at Nova Southeastern University (NSU) and Co-Chair of the Institute’s ALS (Amyotrophic Lateral Sclerosis) Center of Excellence. As a neuroscientist, Dr. Locatelli has been deeply involved in ALS Research including clinical trials sponsored by the Sean M. Healey Center for ALS at Massachusetts General Hospital, ALS genetic studies, and expanded access programs.
Dr. Locatelli earned his Medical Doctorate degree from Universidad de Buenos Aires (UBA), Argentina. He moved to the United States with his family in 1990, and then joined the National Institute of Neurological Disorders and Stroke (NINDS) at the National Institutes of Health (NIH) in Bethesda, Maryland, where he completed an imaging fellowship in Neuroscience, followed by his internship, general Neurology residency—where he was a Chief Resident—and a neuromuscular and epilepsy fellowship at George Washington
University (GWU), in Washington, D.C. Dr. Locatelli joined Cleveland Clinic Florida (CCF) in 2000, opening the first Epilepsy Center in Broward County while also serving as Director of Medical Informatics at CCF. He earned his master’s in public health from NSU in 2005. He then founded the Florida Neuroscience
Center at Holy Cross in 2007, where he started the second Epilepsy Center in Broward County while serving as Chief Medical Information Officer, and later became the Executive Medical Director of the Phil Smith Neuroscience Institute at Holy Cross and led its first ALS Center of Excellence.
Dr. Locatelli strives to serve his community in the best and toughest of times. He was Chief Medical Officer and Incident Commander at Holy Cross Hospital during the COVID-19 pandemic. During his tenure, he led all hospital operations, spearheaded research initiatives seeking viable antiviral treatments, and he was instrumental in the creation of the Vaccination Center.
Dr. Locatelli is the David and Cathy Husman Endowed Chair of the Neuroscience Institute at Nova Southeastern University (NSU) and Co-Chair of the Institute’s ALS (Amyotrophic Lateral Sclerosis) Center of Excellence. As a neuroscientist, Dr. Locatelli has been deeply involved in ALS Research including clinical trials sponsored by the Sean M. Healey Center for ALS at Massachusetts General Hospital, ALS genetic studies, and expanded access programs.
Dr. Locatelli earned his Medical Doctorate degree from Universidad de Buenos Aires (UBA), Argentina. He moved to the United States with his family in 1990, and then joined the National Institute of Neurological Disorders and Stroke (NINDS) at the National Institutes of Health (NIH) in Bethesda, Maryland, where he completed an imaging fellowship in Neuroscience, followed by his internship, general Neurology residency—where he was a Chief Resident—and a neuromuscular and epilepsy fellowship at George Washington
University (GWU), in Washington, D.C. Dr. Locatelli joined Cleveland Clinic Florida (CCF) in 2000, opening the first Epilepsy Center in Broward County while also serving as Director of Medical Informatics at CCF. He earned his master’s in public health from NSU in 2005. He then founded the Florida Neuroscience
Center at Holy Cross in 2007, where he started the second Epilepsy Center in Broward County while serving as Chief Medical Information Officer, and later became the Executive Medical Director of the Phil Smith Neuroscience Institute at Holy Cross and led its first ALS Center of Excellence.
Dr. Locatelli strives to serve his community in the best and toughest of times. He was Chief Medical Officer and Incident Commander at Holy Cross Hospital during the COVID-19 pandemic. During his tenure, he led all hospital operations, spearheaded research initiatives seeking viable antiviral treatments, and he was instrumental in the creation of the Vaccination Center.
